Facial paralysis after superselective intra-arterial chemotherapy via the middle meningeal artery in maxillary cancer.
Previous studies have suggested that the severity of facial paralysis after superselective intra-arterial chemotherapy (SSIAC) is usually mild. Here we present two cases of facial paralysis after SSIAC via the middle meningeal artery (MMA). In case 1, the patient completely recovered from his facial paralysis (to H-B grade I) in 6 months after the onset of paralysis. However, in case 2, his facial movement remained at House-Brackmann (H-B) grade IV with severe synkinesis. We must be careful that SSIAC via the MMA may potentially increase the risk of facial paralysis.
Takanami
Taro
T
Department of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan. taro-taro48@umin.ac.jp
Kondo
Kenji
K
Asakage
Takahiro
T
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D005158:Facial Paralysis / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008576:Meningeal Arteries; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D020127:Recovery of Function
D000970:Antineoplastic Agents